Orbimed Advisors LLC’s Argenx SE Position
Does Orbimed Advisors LLC own Argenx SE (ARGX)? Yes — 136.9K shares worth $100M (+1.98% of its 13F portfolio) as of Q1 2026, down from 146.0K shares the prior filed quarter.
Position Value
$100M
Q1 2026
Shares
136.9K
% of Portfolio
+1.98%
Quarters Held
23
currently held
Position History ARGX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 136.9K | $100M | +1.98% |
| Q4 2025 | 146.0K | $123M | +2.51% |
| Q3 2025 | 172.3K | $127M | +2.99% |
| Q2 2025 | 208.0K | $115M | +2.86% |
| Q1 2025 | 206.7K | $122M | +2.92% |
| Q4 2024 | 189.7K | $117M | +2.40% |
| Q3 2024 | 204.5K | $111M | +2.01% |
| Q2 2024 | 209.1K | $90M | +1.78% |
| Q1 2024 | 151.6K | $60M | +1.09% |
| Q4 2023 | 84.6K | $32M | +0.64% |
| Q3 2023 | 32.6K | $16M | +0.34% |
| Q2 2023 | 32.6K | $13M | +0.23% |
| Q1 2023 | 44.5K | $17M | +0.33% |
| Q4 2022 | 16.2K | $6M | +0.12% |
| Q3 2022 | 269.7K | $95M | +1.77% |
| Q2 2022 | 194.0K | $74M | +1.33% |
| Q1 2022 | 169.8K | $54M | +0.87% |
| Q1 2020 | 28.6K | $4M | +0.06% |
| Q4 2019 | 256.3K | $41M | +0.59% |
| Q3 2019 | 310.4K | $35M | +0.67% |
| Q2 2019 | 310.4K | $44M | +0.68% |
| Q1 2019 | 361.3K | $45M | +0.70% |
| Q4 2018 | 647.6K | $62M | +1.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of ARGX.